Increasing HIV Prevention Access in Rio de Janeiro
Part of Immune system & allergy, Infections clinical trials.
This study helps people at higher risk of HIV get access to PrEP, a daily medication that prevents HIV infection. The program focuses on underserved communities in Rio de Janeiro and aims to make PrEP easier to access and use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 years or older
- You are HIV-negative (confirmed by a screening test)
- You are interested in starting PrEP or getting an HIV test
- You fit into one of the groups the study focuses on: gay or bisexual men, transgender women, sex workers, or women facing financial hardship
- You meet Brazil's national health guidelines for PrEP eligibility
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests online programs to help people who are at higher risk for HIV get prevention or treatment. It aims to see if digital tools can improve access to and use of HIV medications.
This study tests if getting HIV prevention medication (PrEP) from a trained peer in your community works as well as getting it from a clinic. It is for young people aged 15 to 24 who are sexually active and not yet using PrEP.
This study helps transgender women who are not regularly using PrEP (a daily pill to prevent HIV) get access to HIV prevention services. It uses a smartphone to take pictures and connect with support.
This study tests a new approach to help men at risk for HIV stay healthy by providing access to PrEP through a mobile app. The goal is to see if the program helps men start and stay on PrEP compared to standard care.
This study tests ways to help Latino men who have sex with men use PrEP, a medicine that helps prevent HIV. You may be invited if you are HIV-negative (or your status is unknown), are not currently on PrEP, and can read and write Spanish.
This study helps make HIV PrEP (a daily pill to prevent HIV) more available through your regular general practitioner, instead of only at specialized clinics. You may qualify if you are at risk for HIV and want to start or restart PrEP.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.